Stocks
GRAIL, Inc.GRAL
NASDAQHealthcareBiotechnology$45.75
Focused on early cancer detection through blood-based screening, the company develops multi-cancer early detection (MCED) tests designed to identify cancer signals before symptoms appear. Its flagship Galleri test analyzes circulating tumor DNA to screen for dozens of cancer types from a single bloo...
52W Range: $20.44 – $118.84
Congressional Interest in GRAIL, Inc. (GRAL)
1 member of Congress has disclosed 1 trade in GRAIL, Inc. (GRAL), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading GRAL?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-07-11 | JAMES B. RENACCI | buy | $1K – $15K |